Advertisement
Screener

NANOVIRICIDES, INC. (NNVC) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

NANOVIRICIDES, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

NANOVIRICIDES, INC. (NNVC) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7.15 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-05-15

  • NANOVIRICIDES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 7.15M shares, a 118909.66% increase year-over-year.
  • NANOVIRICIDES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-12-31 was 7.15M shares, a 113540.79% increase year-over-year.
  • NANOVIRICIDES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 6.01K shares.
  • NANOVIRICIDES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-12-31 was 6.29K shares.
  • NANOVIRICIDES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 9.15K shares, a 36.56% decline from fiscal 2021.
  • NANOVIRICIDES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 14.42K shares, a 47.04% decline from fiscal 2020.
  • NANOVIRICIDES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 27.22K shares, a 93.25% decline from fiscal 2019.
  • NANOVIRICIDES, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 403.16K shares, a 94.22% decline from fiscal 2018.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-03-317.15M shares
10-Q · filed 2026-05-15		7.15M shares
10-Q · filed 2026-05-15
2025-12-317.15M shares
10-Q · filed 2026-02-17		7.15M shares
10-Q · filed 2026-02-17
2025-03-316.01K shares
10-Q · filed 2026-05-15		6.01K shares
10-Q · filed 2026-05-15
2024-12-316.29K shares
10-Q · filed 2026-02-17		6.29K shares
10-Q · filed 2026-02-17
2022-06-309.15K shares
10-K · filed 2022-10-13
2022-03-319.15K shares
10-Q · filed 2022-05-16
2021-12-319.15K shares
10-Q · filed 2022-02-14
2021-09-309.15K shares
10-Q · filed 2021-11-15
2021-06-3014.42K shares
10-K · filed 2022-10-13		14.15K shares
10-K · filed 2021-10-12
2021-03-3114.15K shares
10-Q · filed 2022-05-16
2020-12-3126.65K shares
10-Q · filed 2022-02-14
2020-09-3026.93K shares
10-Q · filed 2021-11-15
2020-06-3027.22K shares
10-K · filed 2021-10-12
2020-03-3127.50K shares
10-Q · filed 2021-05-14
2019-12-31375.01K shares
10-Q · filed 2021-02-16
2019-09-30403.73K shares
10-Q · filed 2020-11-16
2019-06-30403.16K shares
10-K · filed 2021-10-12		8.06M shares
10-K · filed 2019-08-23
2019-03-31402.86K shares
10-Q · filed 2020-06-22		8.05M shares
10-Q · filed 2019-05-15
2018-12-31221.17K shares
10-Q · filed 2020-02-14		4.42M shares
10-Q · filed 2019-02-14
2018-09-30220.60K shares
10-Q · filed 2019-11-15		4.41M shares
10-Q · filed 2018-11-14
2018-06-306.97M shares
10-K · filed 2019-08-23
2018-03-316.96M shares
10-Q · filed 2019-05-15
2017-12-316.70M shares
10-Q · filed 2019-02-14
2017-09-306.69M shares
10-Q · filed 2018-11-14
2017-06-306.67M shares
10-K · filed 2017-09-28
2017-03-316.66M shares
10-Q · filed 2018-05-21
2016-12-316.65M shares
10-Q · filed 2017-02-14		6.65M shares
10-Q · filed 2018-02-20
2016-09-306.63M shares
10-Q · filed 2017-11-14
2016-06-306.62M shares
10-K · filed 2017-09-28
2016-03-316.60M shares
10-Q · filed 2017-05-15
2015-12-316.01M shares
10-Q · filed 2017-02-14
2015-09-305.99M shares
10-Q · filed 2016-11-14
2015-06-306.51M shares
10-K · filed 2016-09-16
2015-03-316.50M shares
10-Q · filed 2016-05-10
2014-12-316.48M shares
10-Q · filed 2016-02-09
2014-09-306.46M shares
10-Q · filed 2015-11-09
2014-06-309.42M shares
10-K · filed 2015-09-14
2014-03-319.41M shares
10-Q · filed 2015-05-15		9.41M shares
10-Q · filed 2014-05-15
2013-12-316.94M shares
10-Q · filed 2015-02-25		6.94M shares
10-Q · filed 2014-02-14
2013-09-306.93M shares
10-Q/A · filed 2013-11-18		6.92M shares
10-Q/A · filed 2015-02-23
2013-06-303.94M shares
10-K · filed 2015-02-23		3.93M shares
10-Q · filed 2014-02-14
2013-03-313.94M shares
10-Q · filed 2014-05-15
2012-06-303.81M shares
10-K · filed 2015-02-23		13.84M shares
10-K/A · filed 2012-10-26
2011-06-3013.30M shares
10-K/A · filed 2012-10-26
2010-06-3013.07M shares
10-K/A · filed 2012-10-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
BeyondSpring Inc. (BYSI)United States$0.031B-10.95
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Advertisement